Ilsung Pharmaceutical Co Ltd banner

Ilsung Pharmaceutical Co Ltd
KRX:003120

Watchlist Manager
Ilsung Pharmaceutical Co Ltd Logo
Ilsung Pharmaceutical Co Ltd
KRX:003120
Watchlist
Price: 22 700 KRW -0.66% Market Closed
Market Cap: ₩301.9B

Intrinsic Value

The intrinsic value for Ilsung Pharmaceutical Co Ltd (003120) under the Base Case is 12 382.92 KRW. Compared with the current market price of 22 700 KRW, the stock appears Overvalued by 45%.

Intrinsic Value
12 382.92 KRW
Overvaluation 45%
Intrinsic Value
Price ₩22 700
Worst Case
Base Case
Best Case
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value ₩9 906.34
Get notified when the price drops into your buy zone
Current Price ₩22 700
Intrinsic Value ₩12 382.92
Margin of Safety 20% ₩9 906.34
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about Ilsung Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Ilsung Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Ilsung Pharmaceutical Co Ltd.

Explain Valuation
Alternatives to Ilsung Pharmaceutical Co Ltd

Wall St
Price Targets

Dividends

Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one Ilsung Pharmaceutical Co Ltd stock?

The intrinsic value for Ilsung Pharmaceutical Co Ltd (003120) under the Base Case is 12 382.92 KRW.

Is Ilsung Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared with the current market price of 22 700 KRW, the stock appears Overvalued by 45%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett